From September 7, 2022 to October 18, 2022, the company has repurchased 463,678 shares, representing 2.97% for KRW 2,944.46 million. With this, the company has completed the repurchase of 463,678 shares, representing 2.97% for KRW 2,944.46 million under the buyback announced on September 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,250 KRW | -0.79% | -0.79% | +17.48% |
1st Jan change | Capi. | |
---|---|---|
+17.48% | 73.97M | |
+6.56% | 72.03B | |
-10.86% | 5.14B | |
+46.43% | 4.6B | |
+5.38% | 3.96B | |
-16.20% | 2.5B | |
+22.11% | 2.43B | |
-26.20% | 2.32B | |
+19.92% | 2.18B | |
+8.15% | 1.72B |
- Stock Market
- Equities
- A131030 Stock
- News OPTUS Pharmaceutical Co., Ltd.
- Tranche Update on OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 7, 2022.